UBS Maintains a 'Buy' on Visteon (VC); Good News and Bad News
Tweet
Share
E-mailGet Alerts VC Hot Sheet
Price: $108.22 +0.91%
Rating Summary:
21 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
21 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Buy' on Visteon (NYSE: VC) price target raised from $73 to $79.
Analyst, Colin Langan, said, "Adjusted EPS of $0.69 was better than consensus of $0.65, but largely driven by taxes (~$0.20). Adjusted EBITDA of $139m (ex. $11m lighting) missed our $147m estimate. Moreover, we are sceptical that the $50m reduction to adjusted EBITDA guidance is purely related to the divesture and sale-leaseback. We estimate that the underlying EBITDA revision to continuing operations is ~$20m...Despite the guidance revision and Q1 adjusted EBITDA miss, we still remain bullish."
FY12 EPS estimate cut from $4.00 to $3.15 and FY13 lowered from $5.45 to $4.80.
For an analyst ratings summary and ratings history on Visteon click here. For more ratings news on Visteon click here.
Shares of Visteon closed at $48.83 yesterday.
Analyst, Colin Langan, said, "Adjusted EPS of $0.69 was better than consensus of $0.65, but largely driven by taxes (~$0.20). Adjusted EBITDA of $139m (ex. $11m lighting) missed our $147m estimate. Moreover, we are sceptical that the $50m reduction to adjusted EBITDA guidance is purely related to the divesture and sale-leaseback. We estimate that the underlying EBITDA revision to continuing operations is ~$20m...Despite the guidance revision and Q1 adjusted EBITDA miss, we still remain bullish."
FY12 EPS estimate cut from $4.00 to $3.15 and FY13 lowered from $5.45 to $4.80.
For an analyst ratings summary and ratings history on Visteon click here. For more ratings news on Visteon click here.
Shares of Visteon closed at $48.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
- Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
